S100A1 and Miyoshi myopathy: Of the 168 MM patient samples analyzed, there were 4 newly diagnosed MM patients (NDMM) with S100 gain and 1q21 gain, no NDMM samples with S100 gain and no 1q21 gain, 10 NDMM samples with 1q21 gain and no S100 gain, 31 relapsed/refractory MM (RRMM) patients with S100 gain and 1q21 gain, 6 RRMM with S100 gain and no 1q21 gain, and 33 RRMM with 1q21 gain and no S100 gain (Figure 1B and Supplementary Table 2).